HIKAL logo

Hikal Limited

HIKAL·NSE·
201.98 +3.44 (+1.73%)
Market Cap2494.62 Cr
PE Ratio-74.90
Volume60,283
Day High - Low202.99 - 197.01
52W High-Low282.70 - 146.25
DocStoX Score
2.8/10
Poor
Fair Value
Sign in to see
ROE
2.95%
Weak
P/E
-74.90x
Loss-making
Debt / Equity
0.57
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day197.01
202.99
52W146.25
282.70
DocStoX take

Supported by risk (6.6) and valuation (6.0), but held back by growth (0.0).

DocStoX score

Low confidence
2.8
/10
Poor
Quality
Weak
ROE 3.0%
Valuation
Fair
P/B 2.3× on assets (no earnings to value)
Growth
Flat
Revenue -0.1% 5Y CAGR
Risk
Moderate
D/E 0.57
Momentum
Soft
41% of 52-week range

At a glance

Market Cap
₹2,495 Cr
52W High / Low
₹283 / ₹146
Dividend Yield
0.29%
Promoter Holding
68.85%
EPS (TTM)
₹-3.96
Book Value
₹97.20

Key highlights

  • Loss-making — no meaningful P/E
  • Revenue shrinking 0% a year
0 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

HIKAL LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.